176 filings
Page 2 of 9
8-K
qlckx28fueorttj0uq
13 Jun 23
Other Events
4:41pm
8-K
disge9macaxf0hv8qxbj
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
xnp 87519dxs6np
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
bf48t54m
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
r2sj5y8sk bn39pyx1cx
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
kld83
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
ARS
s6vgn0kwfvere3elyg
5 May 23
Annual report to shareholders
4:00pm
8-K
utktl65syw5c 0q81m4j
1 May 23
AVROBIO Announces Leadership Transition
7:40am
S-8
4jvzmoqw7ne9dykxw9c
23 Mar 23
Registration of securities for employees
4:58pm
8-K
tmfl6h84 97
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am
8-K
fxzsx27gcb99w j7k
27 Feb 23
Other Events
4:39pm
8-K
u85v9ps pzot1psj
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
nvaloe tpz6dx
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
l4nrfs
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
1ciw bfzp7
9 Aug 22
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
7:11am